Home
About
Overview
Sharing Data
ORCID
Help
History (68)
Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo.
Sharps injuries and bloodborne pathogen exposures in home health care.
T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming.
Use of atypical antipsychotics in nursing homes and pharmaceutical marketing.
Binge ethanol and liver: new molecular developments.
See All 68 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Binge ethanol and liver: new molecular developments.
Shukla SD, Pruett SB, Szabo G, Arteel GE. Binge ethanol and liver: new molecular developments. Alcohol Clin Exp Res. 2013 Apr; 37(4):550-7.
View in:
PubMed
subject areas
Animals
Binge Drinking
Ethanol
Humans
Inflammation Mediators
Liver
Liver Diseases, Alcoholic
authors with profiles
Gyongyi Szabo MD, PhD